Dr. Blanchet: The Truth in Medical TV Advertising Part I

COLOGUARD : This first stool-based, at home, colorectal screening test detects the presence of red blood cells and DNA mutations that may indicate the presence of certain kinds of abnormal growths that may be colon cancer or precursors to cancer. The question is, How Well Does it Really Work? About 40% of people who need to be screened for colon cancer never do. Could this test be an answer? Join Lindsay and Dr. Bill Blanchet and get the answer.